Financial Information Show all 2021 Q4 Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update Form 10-K Proxy Statements Filing date View 03.30.22 View HTML 0001564590-22-012595.pdf 0001564590-22-012595.xls Form 10-K Filing date View 03.01.22 View HTML 0001564590-22-008112.pdf 0001564590-22-008112.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View 08.08.22 View HTML 0000950170-22-015523.pdf 0000950170-22-015523.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 05.09.22 View HTML 0001564590-22-018873.pdf 0001564590-22-018873.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
